✦ LIBER ✦

A multicenter evaluation of comprehensive analysis of MLL translocations and fusion gene partners in acute leukemia using the MLL FusionChip device

✍ Scribed by Christine J. Harrison; Mike Griffiths; Fìona Moorman; Susanne Schnittger; Jean-Michel Cayuela; Sheila Shurtleff; Enrico Gottardi; Gerlinde Mitterbauer; Dolores Colomer; Eric Delabesse; Vincent Castéras

Book ID: 113513041
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 106 KB
Volume: 173
Category: Article
ISSN: 0165-4608
DOI: 10.1016/j.cancergencyto.2006.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A diagnostic biochip for the comprehensi

A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia

✍ Maroc, N; Morel, A; Beillard, E; de La Chapelle, A L; Fund, X; Mozziconacci, M-J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 327 KB

A three-way translocation of MLL, MLLT11

A three-way translocation of MLL, MLLT11, and the novel reciprocal partner gene MYO18A in a child with acute myeloid leukemia

✍ Marek Ussowicz; Anna Jaśkowiec; Claus Meyer; Rolf Marschalek; Alicja Chybicka; T 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 447 KB

Concurrent translocations of MLL and CBF

Concurrent translocations of MLL and CBFA2 (AML1) genes with new partner breakpoints in a child with secondary myelodysplastic syndrome after treatment of acute lymphoblastic leukemia

✍ Susan Mathew; David Head; Jeffrey E. Rubnitz; Susana C. Raimondi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

The MLL gene at 11q23 is frequently disrupted by chromosomal translocations in de novo acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), and in secondary leukemia induced by treatment with inhibitors of topoisomerase II, including the epipodophylotoxins. The CBFA2 gene at 21q22 is also

585 Analytical and multi-center clinical

585 Analytical and multi-center clinical performance evaluation of a diagnostic device designed to analyze the expression of 11q23/MLL abnormal fusion transcripts in acute leukemia

✍ N. Maroc; V. Castéras; A. Morel; A. Lamy de La Chapelle; C. Harrison; M. Griffit 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Identification of the novel AML1 fusion

Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA

✍ Chinen, Y; Taki, T; Nishida, K; Shimizu, D; Okuda, T; Yoshida, N; Kobayashi, C; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Minimal residual disease-directed risk s

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

✍ Flohr, T; Schrauder, A; Cazzaniga, G; Panzer-Grümayer, R; van der Velden, V; Fis 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 353 KB